2Sudoh T,Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988,332 : 78.
3Tamura N,Ogawa Y,Chusho H,et al. Cardiac fibrosis inmice lacking brain natriuretic pep tide[J]. Proc Natl Acad Sci USA, 2000,97(8) :4239.
4Kapoun AM,Liang F,O Young G,et at. B2 Type natriuretic pep tide exerts broad functional opposition to transforming gr owth factor-β in primary human eardiae fibroblasts[J]. Circulation Research,2004,94(4) :453.
6Maisel AS,Clopton P, Krishnaswamy P, et al. Impact of age, race,and sex on the ability of B2type nat riuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study[J]. Am Heart J,2004,147(6) :107.
7Redfield MM,Rodeheffer RJ ,J acobsen SJ ,et al. Plasma brain natriuretic peptide concent ration: impact of age andgender [J]. J Am Coll Cardiol,2002,40(5):976.
8Iwanaga Y, Kihara Y, Niizuma S, et al. BNP in over-weight and obese patients with heart failure ;an analysis based on the BNPLV diastolic wall stress relationship[J]. J Card Fail, 2007,13(8) :663.
9McCullough PA, Nowak RM, McC ord J, et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational study[J]. Circulation,2002,106(4) :416.
10Lubien E,DeMaria A, K rishnnswany P, et al. Utility of B-natriuretic peptide in detecting diastolic dys function: comparis on with Doppler velocity recordings[J]. Circulation, 2002,105 (5):595.
二级参考文献29
1Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
2Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
3Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
4Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
5Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
6de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
7Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.
8de Denus S,Pharand C,Williamson DR.Brain natriuretic peptide in the management of heart failure:the versatile neurohormone.Chest,2004,125:652-668.
9Colucci WS.Nesiritide for the treatment of decompensated heart failure.J Card Fail,2001,7:92-100.
10Davidson NC,Naos AA,Hanson JK,et al.Comparision of atrial natriuret-ic peptide,B type natriuretic peptide,and N-terminal proatrial natriureticpeptide as indicators of left ventricular systolic dysfunction[].American Journal of Chinese Medicine.1996
8Morrow DA,de Lemos JA,Blazing MA,et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease[J]. JAMA,2005,294(22):2866-71.
9Fertin M,Hennache B,Hamon M,et al. Usefulness of serial assessment of B-type natriuretic peptide, troponin 1,and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVS-2 study)[J]. Am J Cardiol,2010,106(10):1410-6.
